2023 annual financial data
Compass Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -50,363,000 USD and net income was -42,494,000 USD.
Operating cash flow was -40,618,000 USD.
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -50,363,000 USD
- Net income
- -42,494,000 USD
- Operating cash flow
- -40,618,000 USD